Oncology Research

Papers
(The median citation count of Oncology Research is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells36
Programmed Death Ligand-1 (PD-L1) Regulated by NRF-2/MicroRNA-1 Regulatory Axis Enhances Drug Resistance and Promotes Tumorigenic Properties in Sorafenib-Resistant Hepatoma Cells20
Curcumol Inhibits Lung Adenocarcinoma Growth and Metastasis via Inactivation of PI3K/AKT and Wnt/-Catenin Pathway19
lncCRLA Enhanced Chemoresistance in Lung Adenocarcinoma That Underwent EpithelialMesenchymal Transition19
miR-325-3p Promotes the Proliferation, Invasion, and EMT of Breast Cancer Cells by Directly Targeting S100A218
Targeting DNA repair for cancer treatment: Lessons from PARP inhibitor trials18
LncRNA CACNA1G-AS1 up-regulates FTH1 to inhibit ferroptosis and promote malignant phenotypes in ovarian cancer cells17
Long Noncoding RNA LINC02163 Accelerates Malignant Tumor Behaviors in Breast Cancer by Regulating the MicroRNA-511-3p/HMGA2 Axis15
Elucidating the clinical and immunological value of m6A regulator-mediated methylation modification patterns in adrenocortical carcinoma15
Pyrotinib Sensitizes 5-Fluorouracil-Resistant HER2+ Breast Cancer Cells to 5-Fluorouracil15
()-Epigallocatechin-3-Gallate Inhibits EBV Lytic Replication via Targeting LMP1-Mediated MAPK Signal Axes13
miR-142-5p Inhibits Cell Invasion and Migration by Targeting DNMT1 in Breast Cancer12
The effect of Wnt/β-catenin signaling on PD-1/PDL-1 axis in HPV-related cervical cancer11
Is autophagy induction by PARP inhibitors a target for therapeutic benefit?11
Excellent Early Outcomes of Combined Chemotherapy With Arsenic Trioxide for Stage 4/M Neuroblastoma in Children: A Multicenter Nonrandomized Controlled Trial11
A Pilot Study of Silymarin as Supplementation to Reduce Toxicities in Metastatic Colorectal Cancer Patients Treated With First-Line FOLFIRI Plus Bevacizumab10
Targeting triple-negative breast cancer: A clinical perspective10
Endostar, an Antiangiogenesis Inhibitor, Combined With Chemoradiotherapy for Locally Advanced Cervical Cancer10
uPAR Controls Vasculogenic Mimicry Ability Expressed by Drug-Resistant Melanoma Cells10
Construction of the panoptosis-related gene model and characterization of tumor microenvironment infiltration in hepatocellular carcinoma10
Macrophage-derived exosomal miR-342-3p promotes the progression of renal cell carcinoma through the NEDD4L/CEP55 axis9
Drug repositioning of disulfiram induces endometrioid epithelial ovarian cancer cell death via the both apoptosis and cuproptosis pathways9
miR-186 Represses Proliferation, Migration, Invasion, and EMT of Hepatocellular Carcinoma via Directly Targeting CDK69
Anticancer Activity of Novel NF-B Inhibitor DHMEQ by Intraperitoneal Administration9
Evaluation of MGMT Gene Methylation in Neuroendocrine Neoplasms8
Comparison of UGT1A1 Polymorphism as Guidance of Irinotecan Dose Escalation in RAS Wild-Type Metastatic Colorectal Cancer Patients Treated With Cetuximab or Bevacizumab Plus FOLFIRI as t8
Utilization of kinase inhibitors as novel therapeutic drug targets: A review8
CD13: A Key Player in Multidrug Resistance in Cancer Chemotherapy8
CircUCP2 promotes the tumor progression of non-small cell lung cancer through the miR-149/UCP2 pathway8
TBK1 Inhibitor Exerts Antiproliferative Effect on Glioblastoma Multiforme Cells8
Tumor neoantigens: Novel strategies for application of cancer immunotherapy8
The remodeling roles of lipid metabolism in colorectal cancer cells and immune microenvironment7
A Combined Chemical, Computational, and In Vitro Approach Identifies SBL-105 as Novel DHODH Inhibitor in Acute Myeloid Leukemia Cells7
Identification of a Novel Cancer Stemness-Associated ceRNA Axis in Lung Adenocarcinoma via Stemness Indices Analysis7
Long Noncoding RNA LAMTOR5-AS1 Interference Affects MicroRNA-506-3p/E2F6-Mediated Behavior of Non-Small Cell Lung Cancer Cells7
Therapeutic Targeting PLK1 by ON-01910.Na Is Effective in Local Treatment of Retinoblastoma7
circRNAs in drug resistance of breast cancer7
COVID-19 vaccine related hypermetabolic lymph nodes on PET/CT: Implications of inflammatory findings in cancer imaging6
Dissecting the effects of androgen deprivation therapy on cadherin switching in advanced prostate cancer: A molecular perspective6
Regulation of pathological blood-brain barrier for intracranial enhanced drug delivery and anti-glioblastoma therapeutics6
The synergistic effects of PRDX5 and Nrf2 on lung cancer progression and drug resistance under oxidative stress in the zebrafish models6
Long noncoding RNA LINC01124 activates hepatocellular carcinoma cell proliferation, migration, and invasion by absorbing microRNA-1247-5p and overexpressing FOXO36
Progress on diagnostic and prognostic markers of pancreatic cancer6
Computational High-throughput screening and In vitro approaches identify CB-006-3; A novel PI3K-BRAFV600E dual targeted inhibitor against melanoma6
Long Noncoding RNA LINC01703 Exacerbates the Malignant Properties of Non-Small Cell Lung Cancer by Upregulating MACC1 in a MicroRNA-605-3p-Mediated Manner6
Survival and comorbidities in lung cancer patients: Evidence from administrative claims data in Germany5
GABPB1-AS1 acts as a tumor suppressor and inhibits non-small cell lung cancer progression by targeting miRNA-566/F-box protein 475
The role of YAP in the control of the metastatic potential of oral cancer5
cGAS regulates the DNA damage response to maintain proliferative signaling in gastric cancer cells5
LncRNA WEE2-AS1 Knockdown Inhibits the Proliferation, Migration and Invasion of Glioma Cells via Regulating miR-29b- 2-5p/TPM3 Axis5
Computational docking and in vitro analysis identifies novel arylidene analogue FPMXY-14 against renal cancer cells by attenuating Akt5
Biobanking in the digital pathology era5
The LncRNA FEZF1-AS1 promotes tumor proliferation in colon cancer by regulating the mitochondrial protein PCK25
Konjac glucomannan enhances 5-FU-induced cytotoxicity of hepatocellular carcinoma cells via TLR4/PERK/CHOP signaling to induce endoplasmic reticulum stress5
Prognostic Value of EGFR Expression for Patients With Stage III Colorectal Cancer Receiving Fluoropyrimidine Metronomic Maintenance Therapy After Radical Resection and Adjuvant Oxaliplatin-Based Chemo5
Macrophage-derived SHP-2 inhibits the metastasis of colorectal cancer via Tie2-PI3K signals5
Targeting LncRNA LLNLR-299G3.1 with antisense oligonucleotide inhibits malignancy of esophageal squamous cell carcinoma cells in vitro and in vivo5
Long noncoding RNA TMEM147-AS1 serves as a microRNA-326 sponge to aggravate the malignancy of gastric cancer by upregulating SMAD55
A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Gu閞in in patients with non-muscle invasive bladder carcinoma: A retrospective study5
The Implication of microRNAs as non-invasive biomarkers in 179 Egyptian breast cancer female patients5
Long Noncoding RNA TFAP2A-AS1 Exerts Promotive Effects in Non-Small Cell Lung Cancer Progression Via Controlling the microRNA-548a-3p/CDK4 axis as a Competitive Endogenous RNA5
The role of LIN28B in tumor progression and metastasis in solid tumor entities5
RNF43 is a novel tumor-suppressor and prognostic indicator in clear cell renal cell carcinoma5
Comprehensive analysis of the role of immune-related PANoptosis lncRNA model in renal clear cell carcinoma based on RNA transcriptome and single-cell sequencing5
CircMAN1A2 promotes vasculogenic mimicry of nasopharyngeal carcinoma cells through upregulating ERBB2 via sponging miR-9405
STAT3 Polymorphism Associates With mTOR Inhibitor-Induced Interstitial Lung Disease in Patients With Renal Cell Carcinoma4
The role of AFAP1-AS1 in mitotic catastrophe and metastasis of triple-negative breast cancer cells by activating the PLK1 signaling pathway4
Mechanism of NURP1 in temozolomide resistance in hypoxia-treated glioma cells via the KDM3A/TFEB axis4
Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer4
CHRM3 is a novel prognostic factor of poor prognosis and promotes glioblastoma progression via activation of oncogenic invasive growth factors4
Histone deacetylase inhibitors as a novel therapeutic approach for pheochromocytomas and paragangliomas4
Identification of lncRNAs associated with the progression of acute lymphoblastic leukemia using a competing endogenous RNAs network4
Improvement method for cervical cancer detection: A comparative analysis4
PRPF6 promotes metastasis and paclitaxel resistance of ovarian cancer via SNHG16/CEBPB/GATA3 axis4
A Panel of Tumor Biomarkers to Predict Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer4
Long noncoding RNA LINC02568 sequesters microRNA-874-3p to facilitate malignancy in breast cancer cells via cyclin E1 overexpression4
Comprehensive analysis of the expression and prognosis for APOE in malignancies: A pan-cancer analysis4
PPARα activator irbesartan suppresses the proliferation of endometrial carcinoma cells via SREBP1 and ARID1A4
Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer4
MYCN Directly Targets NeuroD1 to Promote Cellular Proliferation in Neuroblastoma4
Review and prospect of immune checkpoint blockade therapy represented by PD-1/PD-L1 in the treatment of clear cell renal cell carcinoma4
Scaffold proteins of cancer signaling networks: The paradigm of FK506 binding protein 51 (FKBP51) supporting tumor intrinsic properties and immune escape4
Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells3
Long non-coding RNA H19 promotes proliferation in hepatocellular carcinoma cells via H19/miR-107/CDK6 axis3
Deciphering key genes involved in cisplatin resistance in kidney renal clear cell carcinoma through a combined in silico and in vitro approach3
The anti-oncogenic effect of 17-DMAG via the inactivation of HSP90 and MET pathway in osteosarcoma cells3
Inhibition of apoptosis-regulatory protein Siva-1 reverses multidrug resistance in gastric cancer by targeting PCBP13
Proteasome Inhibitors Diminish c-Met Expression and Induce Cell Death in Non-Small Cell Lung Cancer Cells3
RNF43 is a Novel Tumor Suppressor and Prognostic Indicator in Clear Cell Renal Cell Carcinoma3
Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring3
The zinc figure protein ZNF575 impairs colorectal cancer growth via promoting p53 transcription3
mTORC2 promotes pancreatic cancer progression and parp inhibitor resistance3
Calcyclin-binding protein contributes to cholangiocarcinoma progression by inhibiting ubiquitination of MCM23
Mini-organs with big impact: Organoids in liver cancer studies3
Mutations in epigenetic regulator KMT2C detected by liquid biopsy are associated with worse survival in prostate cancer patients3
Outcomes of Patients With Acute Myeloid Leukemia Who Relapse After 5 Years of Complete Remission3
0.029755115509033